Skip to main content
PSTV logo

PSTV · Plus Therapeutics, Inc.

$3.83 +0.09 (+2.41%) At close · Jul 20
Market Cap
$26.36M
Shares
6.88M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
65/100
Short interest 14.7% of shares — P95 Days to cover 3.5 — P66 Price vs VWAP -29.2% — P11 Short-volume trend +6.3% — P73 Short interest change -9.4% — P26 Worst FTD 0.22% of shares — P83

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-06-30 1,010,333 1,115,738 -105,405 3.46
2026-06-15 1,115,738 1,144,350 -28,612 8.77
2026-05-29 1,144,350 1,162,255 -17,905 6.46
2026-05-15 1,162,255 1,232,913 -70,658 9.24
2026-04-30 1,232,913 1,348,104 -115,191 4.43
2026-04-15 1,348,104 23,932,707 -22,584,603 1.46
2026-03-31 957,308 804,342 +152,966 4.73
2026-03-13 804,342 806,286 -1,944 4.88
2026-02-27 806,286 975,933 -169,647 4.27
2026-02-13 975,933 962,186 +13,747 3.29
2026-01-30 962,186 454,269 +507,917 1.14
2026-01-15 454,269 293,293 +160,976 1.00
2025-12-31 293,293 282,837 +10,455 2.10
2025-12-15 282,837 295,824 -12,986 1.28
2025-11-28 295,824 310,956 -15,133 1.02
2025-11-14 310,956 314,920 -3,964 2.01
2025-10-31 314,920 77,505 +237,415 1.00
2025-10-15 77,505 668,368 -590,864 1.00
2025-09-30 668,368 162,660 +505,708 1.00
2025-09-15 162,660 186,478 -23,818 1.00
2025-08-29 186,478 124,998 +61,481 1.00
2025-08-15 124,998 74,529 +50,469 1.00
2025-07-31 74,529 149,553 -75,024 1.00
Showing 1–23 of 23 settlements
Key facts CIK 1095981 CUSIP 72941H806 13F (30d) 1 filings 1 filers Visit website Investor relations